文献速递消化、代谢与肾脏急症儿科与产科急症

糖原贮积病Ib型患者的基因变异与临床特征

Genetic Variants and Clinical Features of Patients With Glycogen Storage Disease Type Ib.
PubMed 文献 · JAMA Netw Open · 2025-02-03
一句话结论中国GSDIb队列显示:46%在6.0岁(IQR 3.0-12.0)发生IBD,合并IBD者Δ身高z评分显著更低(-2.99 vs -1.36,P<.001),9%死于并发症。

该回顾性队列研究纳入上海单中心2000年11月1日至2024年6月30日诊治的113例中国GSDIb患者(儿童96例[85%],男性67例[59%]),基因诊断中位年龄1.4岁(范围0.0-35.5),鉴定出38个新发SLC37A4变异。≤2岁以低血糖和代谢紊乱为主(45%),2.1-5.0岁身材矮小(75%)、感染(75%)和反复鼻出血(31%)更常见,呼吸道感染频率在中位7.0岁(IQR 3.5-10.5)后下降。44例(46%)在中位6.0岁(IQR 3.0-12.0)发生IBD,其中14%在中位10.5岁(IQR 5.8-19.6)发生IBD相关关节炎;末次随访实际身高与目标身高z评分差值(Δ身高z评分)均值(SD)-2.11(1.76),即使经生玉米淀粉治疗也未显著增加;合并IBD者Δ身高z评分-2.99(1.70)显著低于无IBD者-1.36(1.44)(P<.001)。10例(9%)死于GSDIb并发症,包括代谢紊乱、脓毒症和/或重症肺炎(n=8)、IBD(n=1)和肺动脉高压(n=1)。

要点

  • 113例中国GSDIb患者基因诊断中位年龄1.4岁(范围0.0-35.5),鉴定出38个新发SLC37A4变异。
  • 44例(46%)发生IBD,中位年龄6.0岁(IQR 3.0-12.0);其中14%发生IBD相关关节炎,中位年龄10.5岁(IQR 5.8-19.6)。
  • 合并IBD者Δ身高z评分-2.99(1.70)显著低于无IBD者-1.36(1.44)(P<.001);总体Δ身高z评分-2.11(1.76),生玉米淀粉治疗后未显著增加。
  • 10例(9%)死于GSDIb并发症:代谢紊乱、脓毒症和/或重症肺炎(n=8)、IBD(n=1)、肺动脉高压(n=1)。
  • ≤2岁以低血糖和代谢紊乱为主(45%);2.1-5.0岁身材矮小(75%)、感染(75%)、反复鼻出血(31%)更常见;呼吸道感染频率在中位7.0岁(IQR 3.5-10.5)后下降。

适用人群与场景

  • 上海单中心2000年11月1日至2024年6月30日诊治的113例中国GSDIb患者,其中儿童96例(85%),男性67例(59%)。

处置流程与药物剂量

  • 生玉米淀粉治疗:原文提及患者接受生玉米淀粉治疗,但未给出剂量、频次或目标值。

红旗征与不能漏的情况

  • 代谢紊乱、脓毒症和/或重症肺炎是GSDIb患者死亡的主要原因(n=8),需警惕。
  • IBD(n=1)和肺动脉高压(n=1)亦可导致死亡。

研究设计与关键结果

  • 研究类型:回顾性队列研究;样本量113例;单中心(上海);人群为中国GSDIb患者。
  • 主要终点:描述基因和临床特征;鉴定出38个新发SLC37A4变异;基因诊断中位年龄1.4岁(范围0.0-35.5)。
  • 临床特征:≤2岁低血糖和代谢紊乱为主(45%);2.1-5.0岁身材矮小(75%)、感染(75%)、反复鼻出血(31%)更常见;呼吸道感染频率在中位7.0岁(IQR 3.5-10.5)后下降。
  • IBD:44例(46%)发生IBD,中位年龄6.0岁(IQR 3.0-12.0);其中14%发生IBD相关关节炎,中位年龄10.5岁(IQR 5.8-19.6)。
  • 生长:末次随访Δ身高z评分均值(SD)-2.11(1.76),生玉米淀粉治疗后未显著增加;合并IBD者-2.99(1.70)显著低于无IBD者-1.36(1.44)(P<.001)。
  • 死亡:10例(9%)死于GSDIb并发症,包括代谢紊乱、脓毒症和/或重症肺炎(n=8)、IBD(n=1)、肺动脉高压(n=1)。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,本研究拓宽了GSDIb的基因和临床谱,提示GSDIb与肠道、生长和生存结局之间存在关联。
  • 作者指出,迄今尚无先前研究报告IBD相关关节炎。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Glycogen storage disease type Ib (GSDIb) is a rare metabolic disorder characterized by impaired glucose-6-phosphate transporter function with limited descriptions.

OBJECTIVE: To describe the genetic and clinical features of Chinese patients with GSDIb.

DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study retrieved the medical records of 113 Chinese patients with GSDIb treated at a single institution in Shanghai from November 1, 2000, to June 30, 2024.

MAIN OUTCOMES AND MEASURES: Biochemical parameters and clinical features (infections, inflammatory bowel disease [IBD], kidney and cardiovascular issues, growth and puberty) at baseline and the last follow-up, all-cause mortality, and mental and social development were assessed.

RESULTS: A total of 113 patients (96 children [85%]; 67 males [59%]) had GSDIb genetically diagnosed at a median age of 1.4 (range, 0.0-35.5) years. Thirty-eight novel SLC37A4 variants were identified. Hypoglycemia and metabolic derangements were the primary concerns in patients aged 2 years or younger (45%). Short stature (75%), infections (75%), and recurrent epistaxis (31%) became more prevalent in patients aged 2.1 to 5.0 years. The frequency of respiratory tract infection decreased after a median age of 7.0 (IQR, 3.5-10.5) years. Forty-four patients (46%) developed IBD at a median age of 6.0 (IQR, 3.0-12.0) years, 14% of whom developed IBD-associated arthritis at a median age of 10.5 (IQR, 5.8-19.6) years. The mean (SD) difference between the z scores of actual height and target height (Δ height z scores) at the final visit (-2.11 [1.76]) did not significantly increase even after uncooked cornstarch treatment. The mean (SD) Δ height z scores of the patients with IBD (-2.99 [1.70]) were significantly lower than those without IBD (mean [SD], -1.36 [1.44]) (P < .001). Ten patients (9%) died due to complications of GSDIb, including metabolic derangements, sepsis, and/or severe pneumonia (n = 8), IBD (n = 1), and pulmonary hypertension (n = 1).

CONCLUSIONS AND RELEVANCE: In this cohort study, the genetic and clinical spectra of GSDIb were broadened, suggesting associations between GSDIb and bowel, growth, and survival outcomes. To date, no previous study reported IBD-associated arthritis.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Xia Y, Sun Y, Du T, et al. Genetic Variants and Clinical Features of Patients With Glycogen Storage Disease Type Ib. JAMA Netw Open. 2025. PMID: 40009380. doi:10.1001/jamanetworkopen.2024.61888

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。